ロード中...

Composite cognitive and functional measures for early stage Alzheimer's disease trials

INTRODUCTION: Composite scales have been advanced as primary outcomes in early stage Alzheimer's disease trials, and endorsed by the U.S. Food and Drug Administration (FDA) for pivotal trials. They are generally composed of several neurocognitive subscales and may include clinical and functiona...

詳細記述

保存先:
書誌詳細
出版年:Alzheimers Dement (Amst)
主要な著者: Schneider, Lon S., Goldberg, Terry E.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7233425/
https://ncbi.nlm.nih.gov/pubmed/32432155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12017
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!